Skip to main content

A systematic review and meta-analysis of randomized controlled trials investigating cognitive behavioural therapy for insomnia in stroke and traumatic brain injury populations

In brief

Insomnia-focused therapy lowers severity scores by 3 points after stroke or brain injury

In a meta-analysis of seven randomized trials, cognitive behavioral therapy for insomnia lowered insomnia severity scores by about 3 points and sleep disturbance scores by about 2 points in people with stroke or traumatic brain injury. Anxiety symptoms also improved modestly, while the reduction in depression symptoms was not statistically significant; the number of trials was small.

Journal
Neuropsychological rehabilitation (Q1)
Published
17 November 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Claudia Evison, Hannah Goodwin, Ashley Vanstone
PMID
43044630
DOI
10.1080/09602011.2026.2763514

Why clinicians should know about it

  • Picked for Rehabilitation (paper of the day, 18 November 2026): Synthesizes CBT-I trials after stroke and traumatic brain injury

Abstract

Insomnia is highly prevalent following stroke and traumatic brain injury (TBI), and can contribute to challenges with mood, psychological functioning and quality of life. Emerging evidence supports the efficacy of cognitive behavioural therapy for insomnia (CBT-I) for those who have experienced stroke or TBI, however a broader review incorporating sleep and mood-related outcomes has not yet been conducted. A systematic literature search was performed on Scopus, PubMed, Embase, and PsycINFO databases. Risk of bias was assessed using the RoB 2.0 tool. Random-effects meta-analyses calculating pooled effect sizes were performed, alongside assessment of heterogeneity and sensitivity analyses. Nine randomised controlled trials were included, with seven contributing to the primary meta-analysis. CBT-I was associated with lower insomnia disorder severity on the ISI (MD = -3.07, 95% CI [-4.46; -1.67], p = 0.0037) and lower sleep disturbance on the PSQI (MD = -1.81, 95% CI [-2.82; -0.80], p = 0.0058). Secondary analyses demonstrated a small, significant effect on anxiety symptoms (Hedges' g = -0.30, 95% CI [-0.49; -0.12], p = 0.0106), and a small-moderate non-significant effect on depressive symptoms (Hedges' g = -0.36, 95% CI [-0.84; 0.12], p = 0.1146). CBT-I appears a promising intervention for improving insomnia after stroke or TBI, with additional modest benefits for depression and anxiety.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.